Concurrent Use of Blinatumomab and Donor Lymphocyte Infusion (DLI) for Treatment of Relapsed Precursor B Cell Acute Lymphoblastic Leukemia (Pre B ALL) After Allogeneic Hematopoietic Cell Transplant (HCT)
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.861
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Elsevier BV